Innovation Pharmaceuticals Inc (IPIX)

[stevo99]

B can take on V or D with ease if the one day treatment holds...

Came across this article:

http://www.biocentury.com/biotech-pharma-news/coverstory/2011-08-01/optimer-cubist-hoping-for-first-line-market-for-antibiotic-dificid-in-cdad-a1

"Initially, we had to communicate with doctors about the rapid bactericidal effects of Cubicin vs. IV vancomycin," Perez said.

Phase III results in 562 patients with cSSTIs showed only 21% of Cubicin patients required >7 days of treatment vs. 60% for the comparator group receiving either vancomycin or a semi-synthetic penicillin; 79% of those receiving once-daily Cubicin required 4-7 days of IV treatment vs. 40% of patients.